ZEB1 and prostate cancer: We had originally expected that knockdown of Zeb1 in mesenchymal PC-3 prostate cancer cells would lead to a mesenchymal-to-epithelial (MET) transition and reduced metastatic cell behaviors such as migration and invasion.